CHAND NAIR: Open Payments
NPI 1164453775 · FORT WASHINGTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$459 in 12 payments from 5 companies in 2025. Trend: 2023 $1,578 · 2024 $651 · 2025 $459
Food & beverage: $459
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 2 | $138 |
| Janssen Pharmaceuticals, Inc | 5 | $126 |
| E.R. Squibb & Sons, L.L.C. | 2 | $111 |
| Otsuka America Pharmaceutical, Inc. | 2 | $55 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $28 |
Products named: ARISTADA, COBENFY, INVEGA SUSTENNA, ABILIFY MAINTENA, CAPLYTA, SPRAVATO, ABILIFY ASIMTUFII.
Industry payments across PA — which companies pay providers there.
